As of the latest SEC filings, HALOZYME THERAPEUTICS, INC. (HALO) is held by 527 institutional funds. The largest fund shareholder is iShares Core S&P Mid-Cap ETF (IJH), holding an estimated $251,638,326.86 in market value, representing 0.24% of its portfolio.
Funds holding HALOZYME THERAPEUTICS, INC. (HALO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- HALO
- CIK:
- 0001159036
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
IJH
iShares Core S&P Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.24% | $251,638,326.86 | 3,893,522 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $241,486,634.24 | 3,736,448 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.11% | $175,862,754.10 | 2,721,070 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.25% | $98,520,808.66 | 1,524,382 | Mar 31, 2026 | May 28, 2026 |
|
JVMAX
Disciplined Value Mid Cap Fund
|
MF | John Hancock | 0.42% | $92,253,831.45 | 1,427,415 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.10% | $84,863,843.36 | 1,313,072 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.11% | $82,370,224.07 | 1,274,489 | Mar 31, 2026 | May 28, 2026 |
|
ODINX
Invesco Discovery Fund
|
MF | Invesco | 1.10% | $72,800,343.55 | 1,047,035 | Feb 28, 2026 | Apr 28, 2026 |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
ETF | First Trust | 3.17% | $71,923,043.09 | 1,112,843 | Mar 31, 2026 | May 28, 2026 |
|
FTXNX
FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH
|
MF | Independent / Boutique | 1.44% | $60,510,160.65 | 936,255 | Mar 31, 2026 | May 28, 2026 |
|
MDY
SPDR S&P MidCap 400 ETF Trust
|
ETF | State Street (SPDR) | 0.24% | $57,284,218.83 | 886,341 | Mar 31, 2026 | Jun 1, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.26% | $56,184,597.18 | 882,573 | Apr 30, 2026 | Jun 26, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.69% | $56,131,284.26 | 868,502 | Mar 31, 2026 | May 28, 2026 |
|
XMHQ
Invesco S&P MidCap Quality ETF
|
ETF | Invesco | 0.99% | $51,232,040.16 | 804,776 | Apr 30, 2026 | Jun 26, 2026 |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
ETF | BlackRock / iShares | 0.27% | $50,288,861.52 | 778,104 | Mar 31, 2026 | May 28, 2026 |
|
IJK
iShares S&P Mid-Cap 400 Growth ETF
|
ETF | BlackRock / iShares | 0.47% | $46,153,834.12 | 714,124 | Mar 31, 2026 | May 28, 2026 |
|
DCCIX
Nomura Small Cap Core Fund
|
MF | Independent / Boutique | 0.78% | $44,839,897.00 | 644,900 | Feb 27, 2026 | Apr 23, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.10% | $42,828,255.04 | 615,968 | Feb 28, 2026 | Apr 24, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.05% | $41,515,791.43 | 642,361 | Mar 31, 2026 | May 28, 2026 |
|
FGSAX
Federated Hermes MDT Mid Cap Growth Fund
|
MF | Federated Hermes | 0.65% | $41,102,588.28 | 645,658 | Apr 30, 2026 | Jun 23, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.19% | $39,684,317.03 | 570,751 | Feb 28, 2026 | Apr 24, 2026 |
|
SPMD
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF
|
ETF | State Street (SPDR) | 0.24% | $37,121,985.51 | 574,377 | Mar 31, 2026 | May 28, 2026 |
|
PNSAX
Putnam Small Cap Growth Fund
|
MF | Independent / Boutique | 1.32% | $35,780,072.82 | 553,614 | Mar 31, 2026 | May 27, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.17% | $31,636,155.30 | 496,955 | Apr 30, 2026 | Jun 24, 2026 |
|
IWF
iShares Russell 1000 Growth ETF
|
ETF | BlackRock / iShares | 0.03% | $30,234,624.93 | 467,811 | Mar 31, 2026 | May 22, 2026 |
Advertisement (320x50)